ONCY
Oncolytics Biotech, Inc.

7,525
Mkt Cap
$121.6M
Volume
1.69M
52W High
$1.51
52W Low
$0.3258
PE Ratio
-4.02
ONCY Fundamentals
Price
$1.02
Prev Close
$1.13
Open
$1.13
50D MA
$0.9977
Beta
0.90
Avg. Volume
1.3M
EPS (Annual)
-$0.3026
P/B
1,412.50
Rev/Employee
$0.00
$59.55
Loading...
Loading...
News
all
press releases
Oncolytics Biotech (ONCY) Expected to Announce Earnings on Friday
Oncolytics Biotech (NASDAQ:ONCY) will be releasing its Q4 2025 earnings before the market opens on Friday, March 6. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire VANCOUVER, BC, Feb. 25, 2026...
PR Newswire·6d ago
News Placeholder
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge PR Newswire VANCOUVER, BC, Feb. 24...
PR Newswire·6d ago
News Placeholder
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire VANCOUVER, BC, Feb. 17, 2026 Issued...
PR Newswire·13d ago
News Placeholder
Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) has been given an average rating of "Moderate Buy" by the seven research firms that are currently covering the firm, MarketBeat Ratings...
MarketBeat·16d ago
News Placeholder
Thomas Charles Heineman Purchases 12,132 Shares of Oncolytics Biotech (NASDAQ:ONCY) Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) insider Thomas Charles Heineman acquired 12,132 shares of the firm's stock in a transaction that occurred on Thursday, February 12th. The stock...
MarketBeat·17d ago
News Placeholder
Oncolytics Biotech (NASDAQ:ONCY) Director Purchases $34,000.00 in Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) Director Bernd Seizinger bought 40,000 shares of Oncolytics Biotech stock in a transaction that occurred on Thursday, February 12th. The stock...
MarketBeat·18d ago
News Placeholder
Oncolytics Biotech (NASDAQ:ONCY) Director Bernd Seizinger Buys 60,000 Shares
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) Director Bernd Seizinger bought 60,000 shares of the business's stock in a transaction dated Wednesday, February 11th. The shares were acquired...
MarketBeat·18d ago
News Placeholder
Oncolytics Biotech (NASDAQ:ONCY) Insider Purchases $25,456.00 in Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) insider Andrew Aromando bought 29,600 shares of the stock in a transaction on Wednesday, February 11th. The shares were bought at an average...
MarketBeat·18d ago
News Placeholder
Patricia Andrews Acquires 35,400 Shares of Oncolytics Biotech (NASDAQ:ONCY) Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) Director Patricia Andrews bought 35,400 shares of Oncolytics Biotech stock in a transaction that occurred on Thursday, February 12th. The...
MarketBeat·18d ago
<
1
2
...
>

Latest ONCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.